Natco Pharma Limited — Updates, 17-10-2025: Press Release
17-10-2025 | 05:08 pm
17-10-2025 | 05:08 pm
NATCO Pharma announces the Supreme Court dismissed Roche's final interim challenge in the Risdiplam suit. This clears a major legal hurdle, enabling NATCO to continue its path to potentially offer affordable SMA treatment in India. The case now proceeds to trial.
No comments yet. Be the first to comment!
